Gastric Motility Disorder Drug Market
Gastric Motility Disorder Drug Market Scope: Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Gastric Motility Disorder Drug Market Size and Growth
The Gastric Motility Disorder Drug market is experiencing growth due to rising prevalence of gastrointestinal disorders and increasing awareness of treatment options. The market is valued at approximately $3 billion, driven by innovations in drug development and a surge in demand for effective therapies. Competitive landscapes are evolving, presenting strategic opportunities.
Companies Covered
(Covid 19 Impact Covered)
◍ Theravance, Inc.
◍ Helsinn Healthcare S.A.
◍ Concert Pharmaceuticals, Inc.
◍ Targacept, Inc.
◍ ChironWells GmbH
The gastric motility disorder drug market features companies like Theravance, Helsinn Healthcare, Concert Pharmaceuticals, Targacept, and ChironWells. They innovate treatments, conduct clinical trials, and enhance patient access. Their efforts contribute to market growth through increased product offerings and awareness.
Sales revenues include:
- Theravance: $123 million
- Helsinn: $125 million
- Concert: $52 million
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Home Use
Request Sample Report
By Product
Velusetrag
Ipamorelin
TD-8954
Others
Market Growth
Request Sample Report
$ X Billion USD
